Position in RCEL
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$321,474
+$318,024 QoQ
Shares Held
86,885
+8588.5% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $129,483,438 across 41 Medical Devices names. RCEL ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
877,072 | $62,429,984 | |
| 2 | ABT |
Abbott Laboratories
|
270,877 | $27,810,941 | |
| 3 | MDT |
Medtronic plc
|
183,368 | $15,888,837 | |
| 4 | SYK |
Stryker Corp
|
29,049 | $9,545,210 | |
| 5 | BSX |
Boston Scientific Corp
|
65,461 | $4,107,677 | |
| 6 | STE |
STERIS plc
|
8,062 | $1,782,750 | |
| 7 | DXCM |
Dexcom Inc
|
26,895 | $1,689,006 | |
| 8 | IRMD |
Iradimed Corp
|
17,191 | $1,654,805 |
All Filings in RCEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,474 | 86,885 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $3,450 | 1,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $5,110 | 1,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,290 | 1,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,140 | 1,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,800 | 1,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||